CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,360,000 | -77.8% | 585,394 | -72.0% | 0.15% | -82.8% |
| Q3 2020 | $15,127,000 | +107.4% | 2,089,356 | 0.0% | 0.87% | +67.1% |
| Q2 2020 | $7,292,000 | +357.2% | 2,089,356 | +93.9% | 0.52% | +263.2% |
| Q1 2020 | $1,595,000 | -89.7% | 1,077,467 | -50.0% | 0.14% | -90.0% |
| Q2 2019 | $15,429,000 | -43.5% | 2,154,934 | +4.8% | 1.45% | -46.9% |
| Q1 2019 | $27,304,000 | +282.9% | 2,056,000 | +126.9% | 2.72% | +198.9% |
| Q4 2018 | $7,130,000 | -29.0% | 906,000 | 0.0% | 0.91% | -10.0% |
| Q3 2018 | $10,038,000 | -17.4% | 906,000 | 0.0% | 1.01% | -35.4% |
| Q2 2018 | $12,158,000 | +17.0% | 906,000 | +13.2% | 1.57% | +6.5% |
| Q1 2018 | $10,392,000 | – | 800,000 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
| Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
| Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
| Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
| Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
| DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
| Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
| Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
| NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
| Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |